Unusual DNA Structure, i-DNA, Linked to Cancer Development by Umeå University Researchers
Researchers at Umeå University in Sweden have made a significant discovery: an unusual DNA structure, known as i-DNA, forms within living cells and functions as a regulatory bottleneck directly linked to cancer development.
What is i-DNA?
i-DNA is a unique, temporary four-stranded structure unlike the familiar double helix. It forms when a single DNA strand folds back on itself, held together by pairs of cytosines. These structures are dynamic, appearing and disappearing in sync with changes in a cell's state, suggesting a crucial role in gene regulation.
A Crucial Role in the Cell Cycle
Previously thought to be too unstable to exist inside cells, new experimental techniques have confirmed that i-DNA forms briefly just before DNA replication begins. This precise timing underscores its importance in cellular processes.
The Regulator: PCBP1 Protein
The study identified the protein PCBP1 as a critical regulator. PCBP1 is responsible for unwinding i-DNA at the appropriate moment, allowing DNA replication to proceed smoothly.
If i-DNA structures are not resolved in time, they can block replication, increasing the risk of DNA damage, which is associated with heightened cancer vulnerability.
i-DNA and Cancer Vulnerability
Researchers also discovered that i-DNA structures vary in their stability. Some are more resistant to unwinding, particularly those with more cytosine base pairs holding them together. Significantly, many i-DNA structures are found in the regulatory regions of oncogenes – genes known to promote cancer. This direct link highlights i-DNA's potential role in the disease.
Innovative Research Techniques
To unravel the mysteries of these short-lived structures, the research team employed a combination of advanced techniques, including biochemical assays, computational modeling, and cell biology. They successfully visualized PCBP1's action in opening i-DNA and captured these structures in living cells during the specific phase of the cell cycle when they emerge.
New Avenues for Cancer Therapy
This groundbreaking discovery reframes i-DNA as a potential target in cancer therapy.
Given that cancer cells often experience replication stress, influencing i-DNA or the PCBP1 protein could push these cells beyond their tolerance limits, opening new avenues for drug development.
The study was a collaborative effort, involving researchers at the Centre National de la Recherche Scientifique (CNRS) in France.